Resona Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.4M Sell
164,151
-12,475
-7% -$4.27M 0.28% 67
2026
Q1
$62.1M Buy
176,626
+3,704
+2% +$1.32M 0.31% 60
2025
Q4
$56.7M Sell
172,922
-5,981
-3% -$1.9M 0.27% 68
2025
Q3
$50.2M Sell
178,903
-8,819
-5% -$2.56M 0.24% 83
2025
Q2
$52.4M Buy
187,722
+7,641
+4% +$2.16M 0.26% 75
2025
Q1
$56M Buy
180,081
+13,390
+8% +$3.95M 0.32% 57
2024
Q4
$43.5M Sell
166,691
-10,349
-6% -$3.07M 0.26% 75
2024
Q3
$57.1M Sell
177,040
-2,321
-1% -$759K 0.33% 56
2024
Q2
$56.1M Sell
179,361
-11,977
-6% -$3.52M 0.34% 53
2024
Q1
$54.4M Buy
+191,338
New +$56M 0.32% 59

Other funds holding AMGN

Resona Asset Management's AMGN Position: Q2 2026 in Review

Resona Asset Management reduced its Amgen (AMGN) stake by 7.1% in Q2 2026, selling an estimated $4.27M and leaving 164,151 shares worth $59.4M. The position accounts for 0.28% of the portfolio, ranked #67.

Resona Asset Management first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $62.1M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Resona Asset Management held 164,151 shares of Amgen worth $59.4M as of Q2 2026.
  • Resona Asset Management sold 12,475 Amgen shares in Q2 2026, an estimated $4.27M.
  • Amgen made up 0.28% of Resona Asset Management's portfolio in Q2 2026, its #67 holding.
  • Resona Asset Management first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Amgen position peaked at $62.1M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.